Ciglitazone, an agonist of peroxisome proliferator-activated receptor gamma, exerts potentiated cytostatic/cytotoxic effects against tumor cells when combined with lovastatin

MLA

Mrówka P, et al. Ciglitazone, an Agonist of Peroxisome Proliferator-Activated Receptor Gamma, Exerts Potentiated Cytostatic/Cytotoxic Effects against Tumor Cells When Combined with Lovastatin. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.dedup.wf.001..4890b72ad66eb5317113e22ed014b737&authtype=sso&custid=ns315887. Accessed 20 Dec. 2024.

APA

Mrówka P, Glodkowska E, Nowis D, Legat M, Tadeusz Issat, Makowski M, Szokalska A, Janowska S, Stoklosa T, Jakóbisiak M, & Golab J. (n.d.). Ciglitazone, an agonist of peroxisome proliferator-activated receptor gamma, exerts potentiated cytostatic/cytotoxic effects against tumor cells when combined with lovastatin.

Chicago

Mrówka P, Glodkowska E, Nowis D, Legat M, Tadeusz Issat, Makowski M, Szokalska A, et al. 2024. “Ciglitazone, an Agonist of Peroxisome Proliferator-Activated Receptor Gamma, Exerts Potentiated Cytostatic/Cytotoxic Effects against Tumor Cells When Combined with Lovastatin.” Accessed December 20. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.dedup.wf.001..4890b72ad66eb5317113e22ed014b737&authtype=sso&custid=ns315887.